Pfizer Significantly Increases Oncology Presence with Medivation Acquisition
By Dan Roberts
Pharma Deals Review: Vol 2016 Issue 8 (Table of Contents)
Published: 26 Aug-2016
DOI: 10.3833/pdr.v2016.i8.2185 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Pfizer and Medivation have announced that they have entered into a definite merger agreement, whereby Pfizer will acquire Medivation for US$81...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS